gene_symbol
CD19
hgnc_id
HGNC:1633
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Blinatumomab links CD3 on T cells to CD19 on target cells, forming an immune synapse and activating T-cell perforin/granzyme-mediated killing of CD19+ cells.
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
B-cell antigen/co-receptor
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06649422
disease_id_num_tar_ref
1651
drug_id_num_tar_ref
4465